Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Ophélie Flageul
CONTACT
Laurent Borderie
CONTACT
Lead
Evolucare Technologies
With
OphtAI-Eval: is a prospective, multicentre, post-marketing clinical follow-up study (SCAC) of diagnostic validation (comparative vs gold standard). It aims to: validate the diagnostic performance of the OphtAI software for the automated screening of diabetic retinopathy, diabetic macular edema, glaucoma, ARM and AMD. Evolucare OphtAI is a medical imaging console for ophthalmology, interfaced with Evolucare Imaging. It allows the detection, by statistical learning algorithms, of the following ocular pathologies using photographs of the retina: * Diabetic retinopathy (DR) (including gradation), * Diabetic macular edema (DME) * Age-related macular degeneration (AMD) * Age-related maculopathy (ARM, early form of AMD), * Glaucoma. Evolucare OphtAI, is available on the French market since March 2019.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
